RSS

narrow spectrum kinase inhibitor (NSKI) drugs

CRO and small scale active pharmaceutical ingredient (API) specialist, Onyx Scientific, has supported biotech company, TopiVert, in the initiation of clinical trials for two narrow spectrum kinase inhibitor (NSKI) drug candidates. more

20 Jul 2017 12:31 News